Precigen, Inc. Gains 25.65%

Fri, Nov 14, 2025 at 07:14 PM

Precigen, Inc. (PGEN:NASDAQ) jumped higher at $4.85, a gain of 25.6%. On Fri, Nov 14, 2025, PGEN:NASDAQ touched a New 2-Week High of $4.85. The stock appeared on our News Catalysts scanner on Fri, Nov 14, 2025 at 02:09 AM in the 'BIOTECH' category. From Fri, Oct 31, 2025, the stock recorded 50.00% Up Days and 54.55% Green Days

The stock spiked on Wed, Sep 03, 2025 at $5.23 with a volume of 9M+.

About Precigen, Inc. (PGEN:NASDAQ)

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Top 10 Gainers:

Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
Cidara Therapeutics, Inc. (CDTX:NASDAQ), 105.41%
Cypherpunk Technologies Inc Com (New) (CYPH:NASDAQ), 56.25%
Cycurion, Inc. (CYCU:NASDAQ), 51.2%
Invivyd, Inc. (IVVD:NASDAQ), 32.77%
The Oncology Institute, Inc. (TOI:NASDAQ), 28.9%
NOMADAR Corp. (NOMA:NASDAQ), 26.46%
Connect Biopharma Holdings Limited (CNTB:NASDAQ), 26.19%
Precigen, Inc. (PGEN:NASDAQ), 25.65%
Omeros Corporation (OMER:NASDAQ), 25.32%